 Alexander Barker
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 62 | 2024 | 401 | 10.640 |
Why?
| | Heart Valve Diseases | 50 | 2024 | 161 | 9.420 |
Why?
| | Hemodynamics | 75 | 2024 | 1014 | 8.890 |
Why?
| | Aorta | 55 | 2024 | 390 | 8.060 |
Why?
| | Magnetic Resonance Angiography | 38 | 2024 | 221 | 6.940 |
Why?
| | Magnetic Resonance Imaging | 79 | 2024 | 3053 | 6.140 |
Why?
| | Imaging, Three-Dimensional | 51 | 2024 | 517 | 5.860 |
Why?
| | Blood Flow Velocity | 71 | 2024 | 387 | 5.840 |
Why?
| | Magnetic Resonance Imaging, Cine | 34 | 2024 | 174 | 4.720 |
Why?
| | Aorta, Thoracic | 21 | 2023 | 257 | 4.020 |
Why?
| | Aortic Valve Stenosis | 22 | 2022 | 272 | 3.750 |
Why?
| | Image Interpretation, Computer-Assisted | 25 | 2024 | 224 | 3.600 |
Why?
| | Stress, Mechanical | 31 | 2024 | 447 | 3.030 |
Why?
| | Aortic Diseases | 18 | 2022 | 109 | 2.540 |
Why?
| | Pulmonary Artery | 17 | 2024 | 1028 | 2.170 |
Why?
| | Predictive Value of Tests | 31 | 2024 | 1801 | 2.090 |
Why?
| | Aortic Aneurysm, Thoracic | 7 | 2023 | 122 | 2.080 |
Why?
| | Regional Blood Flow | 20 | 2024 | 424 | 2.000 |
Why?
| | Fetal Heart | 3 | 2024 | 37 | 1.890 |
Why?
| | Ventricular Function, Left | 16 | 2024 | 468 | 1.840 |
Why?
| | Vascular Stiffness | 17 | 2024 | 408 | 1.830 |
Why?
| | Pregnancy Trimester, Third | 2 | 2024 | 78 | 1.820 |
Why?
| | Heart Ventricles | 17 | 2024 | 711 | 1.640 |
Why?
| | Shear Strength | 12 | 2024 | 65 | 1.450 |
Why?
| | Perfusion Imaging | 14 | 2024 | 51 | 1.390 |
Why?
| | Reproducibility of Results | 30 | 2024 | 2770 | 1.380 |
Why?
| | Tetralogy of Fallot | 8 | 2022 | 84 | 1.260 |
Why?
| | Humans | 163 | 2024 | 114937 | 1.150 |
Why?
| | Image Enhancement | 9 | 2022 | 162 | 1.150 |
Why?
| | Female | 108 | 2024 | 59581 | 1.080 |
Why?
| | Hypertension, Pulmonary | 11 | 2023 | 1737 | 1.070 |
Why?
| | Heart Valve Prosthesis Implantation | 6 | 2019 | 175 | 1.000 |
Why?
| | Contrast Media | 9 | 2022 | 353 | 0.990 |
Why?
| | Image Processing, Computer-Assisted | 10 | 2021 | 686 | 0.990 |
Why?
| | Male | 105 | 2024 | 55663 | 0.950 |
Why?
| | Fontan Procedure | 8 | 2024 | 157 | 0.940 |
Why?
| | Retrospective Studies | 44 | 2024 | 12544 | 0.910 |
Why?
| | Heart Defects, Congenital | 11 | 2023 | 665 | 0.910 |
Why?
| | Ventricular Function, Right | 12 | 2024 | 252 | 0.910 |
Why?
| | Adult | 62 | 2024 | 30608 | 0.890 |
Why?
| | Terminology as Topic | 3 | 2021 | 187 | 0.860 |
Why?
| | Iothalamic Acid | 1 | 2022 | 4 | 0.850 |
Why?
| | Young Adult | 40 | 2024 | 10478 | 0.840 |
Why?
| | Middle Aged | 59 | 2024 | 26806 | 0.820 |
Why?
| | Observer Variation | 6 | 2023 | 297 | 0.820 |
Why?
| | Cardiac Surgical Procedures | 5 | 2020 | 414 | 0.820 |
Why?
| | Cardiac-Gated Imaging Techniques | 9 | 2020 | 16 | 0.800 |
Why?
| | Aortic Coarctation | 6 | 2024 | 69 | 0.780 |
Why?
| | Pulmonary Circulation | 6 | 2019 | 408 | 0.750 |
Why?
| | Hydrodynamics | 4 | 2022 | 37 | 0.740 |
Why?
| | Ventricular Dysfunction, Right | 6 | 2022 | 218 | 0.740 |
Why?
| | Problem-Based Learning | 1 | 2021 | 78 | 0.740 |
Why?
| | Gestational Age | 1 | 2023 | 759 | 0.730 |
Why?
| | Electrocardiography | 4 | 2020 | 562 | 0.720 |
Why?
| | Anesthesia | 1 | 2022 | 117 | 0.700 |
Why?
| | Bicuspid | 2 | 2018 | 13 | 0.690 |
Why?
| | Models, Cardiovascular | 9 | 2021 | 178 | 0.690 |
Why?
| | Echocardiography, Doppler | 4 | 2022 | 93 | 0.690 |
Why?
| | Arterial Pressure | 6 | 2019 | 99 | 0.680 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2020 | 360 | 0.670 |
Why?
| | Child | 38 | 2024 | 18366 | 0.650 |
Why?
| | Aged | 36 | 2024 | 19122 | 0.640 |
Why?
| | Case-Control Studies | 20 | 2023 | 3008 | 0.620 |
Why?
| | Pulse Wave Analysis | 9 | 2023 | 208 | 0.610 |
Why?
| | Adolescent | 37 | 2024 | 17829 | 0.610 |
Why?
| | Severity of Illness Index | 11 | 2019 | 2542 | 0.580 |
Why?
| | Sensitivity and Specificity | 12 | 2016 | 1700 | 0.580 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2024 | 110 | 0.560 |
Why?
| | Algorithms | 9 | 2018 | 1474 | 0.540 |
Why?
| | Cardiac Imaging Techniques | 8 | 2021 | 21 | 0.540 |
Why?
| | Aortic Aneurysm | 6 | 2024 | 56 | 0.530 |
Why?
| | Aortography | 3 | 2021 | 50 | 0.530 |
Why?
| | Prospective Studies | 17 | 2024 | 6218 | 0.520 |
Why?
| | Kidney | 1 | 2022 | 1184 | 0.520 |
Why?
| | Feasibility Studies | 10 | 2019 | 737 | 0.510 |
Why?
| | Systole | 9 | 2022 | 171 | 0.500 |
Why?
| | Gadolinium DTPA | 2 | 2018 | 47 | 0.500 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 1729 | 0.480 |
Why?
| | Myocardial Perfusion Imaging | 6 | 2020 | 34 | 0.460 |
Why?
| | Stroke Volume | 9 | 2022 | 510 | 0.450 |
Why?
| | Reference Values | 7 | 2023 | 741 | 0.450 |
Why?
| | Hemorheology | 1 | 2013 | 20 | 0.450 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 27 | 0.440 |
Why?
| | Marfan Syndrome | 3 | 2018 | 43 | 0.440 |
Why?
| | Dilatation, Pathologic | 6 | 2024 | 57 | 0.420 |
Why?
| | Norwood Procedures | 2 | 2024 | 22 | 0.420 |
Why?
| | Pilot Projects | 9 | 2022 | 1372 | 0.400 |
Why?
| | Age Factors | 10 | 2024 | 2891 | 0.390 |
Why?
| | Vascular Remodeling | 5 | 2019 | 153 | 0.380 |
Why?
| | Heart Valve Prosthesis | 4 | 2017 | 121 | 0.380 |
Why?
| | Computer Simulation | 4 | 2021 | 880 | 0.360 |
Why?
| | Mitral Valve Stenosis | 2 | 2022 | 21 | 0.350 |
Why?
| | Phenotype | 9 | 2021 | 2817 | 0.350 |
Why?
| | Coronary Circulation | 8 | 2020 | 134 | 0.340 |
Why?
| | Biomechanical Phenomena | 6 | 2023 | 672 | 0.340 |
Why?
| | Phantoms, Imaging | 4 | 2022 | 122 | 0.340 |
Why?
| | Postoperative Complications | 5 | 2020 | 2133 | 0.310 |
Why?
| | Cardiovascular System | 2 | 2023 | 126 | 0.310 |
Why?
| | Child, Preschool | 14 | 2022 | 9086 | 0.300 |
Why?
| | Ventricular Remodeling | 5 | 2022 | 227 | 0.280 |
Why?
| | Heart Function Tests | 2 | 2019 | 58 | 0.280 |
Why?
| | Cross-Sectional Studies | 7 | 2024 | 4407 | 0.270 |
Why?
| | Principal Component Analysis | 2 | 2024 | 176 | 0.270 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2024 | 3248 | 0.260 |
Why?
| | Infant, Newborn | 5 | 2023 | 5035 | 0.260 |
Why?
| | Aging | 1 | 2015 | 1621 | 0.260 |
Why?
| | Cross-Over Studies | 2 | 2024 | 441 | 0.250 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2019 | 182 | 0.250 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 42 | 0.240 |
Why?
| | Myocardial Contraction | 3 | 2020 | 312 | 0.230 |
Why?
| | Pregnancy | 3 | 2024 | 5527 | 0.230 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2015 | 122 | 0.220 |
Why?
| | Artifacts | 2 | 2022 | 113 | 0.220 |
Why?
| | Infant | 9 | 2024 | 7937 | 0.220 |
Why?
| | Echocardiography | 5 | 2022 | 555 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2326 | 0.220 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 168 | 0.220 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 63 | 0.200 |
Why?
| | Anesthesia, General | 1 | 2022 | 45 | 0.200 |
Why?
| | Respiratory-Gated Imaging Techniques | 3 | 2018 | 10 | 0.200 |
Why?
| | Ultrasonography, Prenatal | 1 | 2023 | 236 | 0.200 |
Why?
| | Biomedical Engineering | 1 | 2021 | 24 | 0.200 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 928 | 0.200 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 604 | 0.200 |
Why?
| | Coronary Vessels | 2 | 2021 | 230 | 0.190 |
Why?
| | Prenatal Care | 1 | 2024 | 255 | 0.190 |
Why?
| | Body Fluids | 1 | 2021 | 58 | 0.190 |
Why?
| | Time Factors | 10 | 2024 | 6125 | 0.190 |
Why?
| | Healthy Volunteers | 3 | 2017 | 197 | 0.190 |
Why?
| | Biomarkers | 5 | 2023 | 3418 | 0.190 |
Why?
| | Consensus | 5 | 2021 | 534 | 0.190 |
Why?
| | Respiration | 1 | 2022 | 180 | 0.190 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 28 | 0.190 |
Why?
| | Creatinine | 1 | 2022 | 424 | 0.190 |
Why?
| | Bioprosthesis | 3 | 2015 | 36 | 0.180 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.180 |
Why?
| | Body Surface Area | 1 | 2020 | 27 | 0.180 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 290 | 0.180 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 96 | 0.180 |
Why?
| | Aortic Valve Insufficiency | 2 | 2018 | 46 | 0.180 |
Why?
| | Cardiac Catheterization | 6 | 2023 | 535 | 0.180 |
Why?
| | Sinus of Valsalva | 1 | 2019 | 11 | 0.170 |
Why?
| | Mechanotransduction, Cellular | 1 | 2021 | 97 | 0.170 |
Why?
| | Intracranial Aneurysm | 1 | 2021 | 91 | 0.170 |
Why?
| | Fetus | 1 | 2023 | 701 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2021 | 4427 | 0.170 |
Why?
| | Echocardiography, Four-Dimensional | 2 | 2016 | 2 | 0.160 |
Why?
| | Blood Volume | 2 | 2016 | 59 | 0.160 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2022 | 39 | 0.160 |
Why?
| | Sleep | 1 | 2024 | 632 | 0.160 |
Why?
| | Endothelium, Vascular | 2 | 2016 | 848 | 0.160 |
Why?
| | Aorta, Abdominal | 2 | 2015 | 39 | 0.160 |
Why?
| | Prognosis | 7 | 2021 | 3344 | 0.160 |
Why?
| | Elastic Tissue | 1 | 2018 | 8 | 0.160 |
Why?
| | Tricuspid Valve | 2 | 2015 | 25 | 0.160 |
Why?
| | Turner Syndrome | 1 | 2018 | 45 | 0.150 |
Why?
| | Viscosity | 2 | 2019 | 81 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 63 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 76 | 0.140 |
Why?
| | Heart Transplantation | 1 | 2023 | 667 | 0.140 |
Why?
| | Blood Pressure | 3 | 2019 | 1537 | 0.140 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 113 | 0.140 |
Why?
| | Peptide Fragments | 1 | 2021 | 668 | 0.140 |
Why?
| | Disease Progression | 6 | 2019 | 2392 | 0.140 |
Why?
| | Heart Rate | 1 | 2020 | 705 | 0.140 |
Why?
| | Rheology | 1 | 2017 | 86 | 0.140 |
Why?
| | Mitral Valve | 1 | 2017 | 87 | 0.130 |
Why?
| | Endocardium | 1 | 2016 | 30 | 0.130 |
Why?
| | Arteries | 1 | 2018 | 247 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 827 | 0.130 |
Why?
| | Treatment Outcome | 8 | 2024 | 9105 | 0.130 |
Why?
| | Carotid Arteries | 1 | 2017 | 180 | 0.130 |
Why?
| | Analysis of Variance | 3 | 2014 | 1227 | 0.130 |
Why?
| | Databases, Factual | 2 | 2017 | 1125 | 0.130 |
Why?
| | Biomedical Research | 1 | 2021 | 585 | 0.130 |
Why?
| | Preoperative Care | 1 | 2017 | 317 | 0.130 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2015 | 4 | 0.130 |
Why?
| | Splanchnic Circulation | 1 | 2015 | 12 | 0.130 |
Why?
| | Cerebrovascular Disorders | 1 | 2016 | 82 | 0.120 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 99 | 0.120 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 607 | 0.120 |
Why?
| | Angiography | 1 | 2015 | 176 | 0.120 |
Why?
| | Atherosclerosis | 2 | 2021 | 342 | 0.120 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 38 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 495 | 0.120 |
Why?
| | Portal Vein | 1 | 2015 | 76 | 0.120 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2014 | 38 | 0.110 |
Why?
| | Brain Mapping | 1 | 2017 | 522 | 0.110 |
Why?
| | Heart | 3 | 2023 | 609 | 0.110 |
Why?
| | Subtraction Technique | 1 | 2013 | 24 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 288 | 0.110 |
Why?
| | Ultrasonography | 1 | 2017 | 633 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2015 | 220 | 0.110 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 96 | 0.110 |
Why?
| | Carotid Artery, Internal | 1 | 2013 | 36 | 0.110 |
Why?
| | Endarterectomy, Carotid | 1 | 2013 | 42 | 0.110 |
Why?
| | Multimodal Imaging | 1 | 2013 | 92 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 190 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2013 | 44 | 0.100 |
Why?
| | Carotid Stenosis | 1 | 2013 | 79 | 0.100 |
Why?
| | Femoral Artery | 1 | 2013 | 167 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2014 | 183 | 0.100 |
Why?
| | Systematized Nomenclature of Medicine | 2 | 2021 | 12 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2016 | 685 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 387 | 0.090 |
Why?
| | Cohort Studies | 3 | 2021 | 4903 | 0.090 |
Why?
| | Vasodilation | 1 | 2013 | 416 | 0.090 |
Why?
| | RNA | 1 | 2016 | 810 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2096 | 0.090 |
Why?
| | Dilatation | 2 | 2021 | 60 | 0.090 |
Why?
| | Risk Factors | 6 | 2020 | 8637 | 0.080 |
Why?
| | Diastole | 2 | 2020 | 131 | 0.080 |
Why?
| | Swine | 3 | 2016 | 701 | 0.080 |
Why?
| | Patient-Specific Modeling | 2 | 2020 | 36 | 0.080 |
Why?
| | Motion | 2 | 2019 | 90 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2102 | 0.080 |
Why?
| | Peripheral Arterial Disease | 1 | 2013 | 380 | 0.070 |
Why?
| | Radiography | 2 | 2024 | 819 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 485 | 0.070 |
Why?
| | Calibration | 2 | 2017 | 125 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2013 | 929 | 0.070 |
Why?
| | Blood Volume Determination | 2 | 2016 | 5 | 0.070 |
Why?
| | Vena Cava, Inferior | 2 | 2016 | 56 | 0.060 |
Why?
| | Elasticity | 2 | 2017 | 190 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1019 | 0.060 |
Why?
| | Linear Models | 2 | 2017 | 770 | 0.060 |
Why?
| | Actigraphy | 1 | 2024 | 74 | 0.060 |
Why?
| | Risk Assessment | 3 | 2018 | 2975 | 0.060 |
Why?
| | Technology | 1 | 2024 | 79 | 0.060 |
Why?
| | Bromocriptine | 1 | 2022 | 26 | 0.050 |
Why?
| | Prevalence | 2 | 2023 | 2252 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 473 | 0.050 |
Why?
| | Sex Factors | 2 | 2017 | 1721 | 0.050 |
Why?
| | Stents | 2 | 2015 | 476 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 416 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 137 | 0.050 |
Why?
| | Heart Failure | 1 | 2013 | 1952 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 61 | 0.040 |
Why?
| | Obesity | 2 | 2023 | 2514 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 372 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1663 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 472 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 642 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2015 | 6364 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 141 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | User-Computer Interface | 1 | 2019 | 144 | 0.040 |
Why?
| | Gadolinium | 1 | 2018 | 75 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 136 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 911 | 0.040 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2017 | 18 | 0.040 |
Why?
| | Organometallic Compounds | 1 | 2018 | 98 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2019 | 338 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 56 | 0.040 |
Why?
| | Perfusion | 1 | 2017 | 150 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 496 | 0.040 |
Why?
| | Preoperative Period | 1 | 2017 | 103 | 0.030 |
Why?
| | Genomic Library | 1 | 2016 | 15 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 21 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 724 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2015 | 16 | 0.030 |
Why?
| | Extracellular Fluid | 1 | 2015 | 30 | 0.030 |
Why?
| | Pulsatile Flow | 1 | 2015 | 54 | 0.030 |
Why?
| | Risk | 1 | 2018 | 815 | 0.030 |
Why?
| | Splenic Artery | 1 | 2015 | 13 | 0.030 |
Why?
| | Elastin | 1 | 2015 | 78 | 0.030 |
Why?
| | Mesenteric Artery, Superior | 1 | 2015 | 12 | 0.030 |
Why?
| | Liver Circulation | 1 | 2015 | 19 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 467 | 0.030 |
Why?
| | Heart Atria | 1 | 2016 | 110 | 0.030 |
Why?
| | Hepatic Artery | 1 | 2015 | 48 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 448 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2015 | 89 | 0.030 |
Why?
| | Postoperative Period | 1 | 2015 | 289 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 853 | 0.030 |
Why?
| | Animals | 4 | 2016 | 31839 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 285 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2017 | 516 | 0.030 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 31 | 0.030 |
Why?
| | Observational Studies as Topic | 1 | 2013 | 90 | 0.030 |
Why?
| | Quality Control | 1 | 2013 | 144 | 0.030 |
Why?
| | Pericardium | 1 | 2013 | 49 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2013 | 122 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1644 | 0.030 |
Why?
| | Sheep | 1 | 2015 | 764 | 0.030 |
Why?
| | Recurrence | 1 | 2015 | 937 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1440 | 0.020 |
Why?
| | Forecasting | 1 | 2013 | 333 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2012 | 177 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 330 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1523 | 0.020 |
Why?
| | United States | 1 | 2018 | 12211 | 0.010 |
Why?
|
|
Barker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|